Biotech · Private company
CinDome Pharma, Inc.
Track this companyFree. Adds CinDome Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- CIN-102 Dose 1Phase 2 · Diabetic GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
- CIN-102 Dose 1Phase 2 · GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
- CIN-102 Dose 10mgPhase 2 · Idiopathic GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
- CIN-102 Dose 15mgPhase 2 · Idiopathic GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
- CIN-102 Dose 15mg or 10mgPhase 2 · Diabetic GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
- CIN-102 Dose 2Phase 2 · Diabetic GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
- CIN-102 Dose 2Phase 2 · GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
- CIN-102 Dose 3Phase 2 · GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.PHASE2 · COMPLETED · started Jan 29, 2025ClinicalTrials.gov NCT06899217 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic GastroparesisPHASE2 · COMPLETED · started Mar 27, 2023ClinicalTrials.gov NCT05832151 · fetched Nov 12, 2026
- A Scintigraphy Study in Adults With Diabetic GastroparesisPHASE2 · TERMINATED · started Feb 17, 2020ClinicalTrials.gov NCT04208698 · fetched Nov 12, 2026
- A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic GastroparesisPHASE2 · TERMINATED · started Sep 11, 2019ClinicalTrials.gov NCT04026997 · fetched Nov 12, 2026